FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: blood

Sort
E.g., 2013-05-23
E.g., 2013-05-23
Enter a comma separated list of user names.

PANL, CFI, CO, - CRWESelect.com Stock Report! Universal Display, Culp, China Cord Blood ( Video Icluded Inside )
Posted by CRWESelect Stoc... on August 29th, 2011

To View Video Click or Visit URL Link Here: http://crweselect.com/25870/stock-alerts/panl-cfi-co-crweselectcom-stock...

Universal Display Corp. (NASDAQ:PANL)

Read More
comment 0
Share
Tags:
Stocks, blood, stem cell, CFI, nasdaq:panl, universal display, CO, hematopoietic stem cell processing, NYSE:CO, Furniture, stock report, China Cord Blood, Culp, NYSE:CFI, Select, PANL, Stock News, Stock Highlights, organic light emitting device, OLED, UniversalPHOLED, phosphorescent OLED technology, Stock Market Watch, blood banking, commercial upholstered furniture, fabrics for furniture, laboratory testing, mattress fabrics, OLED Lighting, OLED lighting products, Panasonic Idemitsu, stem cell storage services

AVOT.PK, SVNT, ERTS, APCVZ, - American Video Teleconferencing Corp., Savient Pharmaceuticals, Electronic Arts

Posted by CRWESelect Stoc... on November 1st, 2010
Read More
comment 0
Share
Tags:
ERTS, blood, electronic arts, Software Company, NASDAQ:SVNT, Savient Pharmaceuticals, SVNT, NASDAQ:ERTS, biopharmaceutical company, American Video Teleconferencing, AVOT.PK, Mekinac, Lajuene, PINK:AVOT, AVOT, apcvz, enteral nutrition, Fresenius Kabi Pharmaceuticals, I.V. drugs, NASDAQ:APCVZ, parenteral nutrition

Northfield Laboratories Inc.’s (NFLD) Application for PolyHeme Accepted for Filing and Granted Priority Review
Posted by QualityStocks.net on December 30th, 2008

Northfield Laboratories announced that the U.S. FDA has approved the filing of the Biologics License Application (BLA) for PolyHeme®, the company’s investigative human hemoglobin-based red cell substitute developed to treat life-threatening red blood cell loss when red blood cells are not available.

Read More
comment 0
Share
Tags:
blood, fda, hemoglobin, priority review, gould, polyheme, surgeon

Insmed Inc. (INSM) Shares Climb 15% on Word of Positive Bioequivalence Testing
Posted by QualityStocks.net on July 11th, 2008

Shares of Insmed Inc. (Nasdaq: INSM) hiked 15% to a close of 46 cents yesterday, spurred by word the biopharmaceutical company has demonstrated the bioequivalence of INS-19, the company’s recombinant human granulocyte colony stimulating factor (G-CSF).

Read More
comment 0
Share
Tags:
cells, blood, biopharmaceutical, fda, bioequivalaence, white

Synthetic Blood International, Inc. (SYBD.OB) Receives Grants Exceeding $5 Million
Posted by QualityStocks.net on June 20th, 2008

The Department of Defense has awarded Synthetic Blood International a number of grants totaling more than $5.3 million. The funding from these grants will be used to study clinical applications for Oxycyte®, company’s perfluorocarbon therapeutic oxygen carrier.

Read More
comment 0
Share
Tags:
therapeutic, blood, oxycyte, oxygen

ImmunoCellular Therapeutics, Ltd. (IMUC.OB) Announces Research Agreement with George Mason University
Posted by QualityStocks.net on June 20th, 2008

ImmunoCellular Therapeutics has signed a research agreement with George Mason University for the development of a blood test designed to detect small cell lung cancer and pancreatic cancer using ImmunoCellular’s monoclonal antibody technology.

Read More
comment 0
Share
Tags:
university, george, mason, blood, lung, cancer, pancreatic

ADVERTISE WITH US